Cited by 179Mesenchymal stem cell researchCancer Cells and MetastasisAngiogenesis and VEGF in Cancer

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors

Open access
Klopp, Ann H., Zhang, Yan, Solley, Travis, Amaya-Manzanares, Felipe, Marini, Frank, Andreeff, Michael, Debeb, Bisrat, Woodward, Wendy, Schmandt, Rosemarie, Broaddus, Russell, Lu, Karen, Kolonin, Mikhail G.·2012·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Adipose tissue contains a population of tumor-tropic mesenchymal progenitors, termed adipose stromal cells (ASC), which engraft in neighboring tumors to form supportive tumor stroma. We hypothesized that intra-abdominal visceral adipose tissue may contain a uniquely tumor-promoting population of ASC to account for the relationship between excess visceral adipose tissue and mortality of intra-abdominal cancers. Experimental Design: To investigate this, we isolated and characterized ASC from intra-abdominal omental adipose tissue (O-ASC) and characterized their effects on endometrial cancer progression as compared with subcutaneous adipose-derived mesenchymal stromal cells (SC-ASC), bone marrow–derived mesenchymal stromal cells (BM-MSC), and lung fibroblasts. To model chronic recruitment of ASC by tumors, cells were injected metronomically into mice bearing Hec1a xenografts. Results: O-ASC expressed cell surface markers characteristic of BM-MSC and differentiated into mesenchymal lineages. Coculture with O-ASC increased endometrial cancer cell proliferation in vitro. Tumor tropism of O-ASC and SC-ASC for human Hec1a endometrial tumor xenografts was comparable, but O-ASC more potently promoted tumor growth. Compared with tumors in SC-ASC–injected mice, tumors in O-ASC–injected mice contained higher numbers of large tortuous desmin-positive blood vessels, which correlated with decreased central tumor necrosis and increased tumor cell proliferation. O-ASC exhibited enhanced motility as compared with SC-ASC in response to Hec1a-secreted factors. Conclusions: Visceral adipose tissue contains a population of multipotent MSCs that promote endometrial tumor growth more potently than MSCs from subcutaneous adipose tissue. We propose that O-ASCs recruited to tumors express specific factors that enhance tumor vascularization, promoting survival and proliferation of tumor cells. Clin Cancer Res; 18(3); 771–82. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-1916

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both bone marrow-derived and adipose-derived MSC show tumor tropism driven by various tumor-released chemotactic factors, including CCL25, CXCL1, EGF, HDGF, IL-8, PDGF, SDF1, TGFβ and VEGF.

    “Both BM- and adipose-derived MSC display tumor tropism due to various tumor-released chemotactic factors including CCL25 [43], C-X-C motif chemokine-1 (CXCL1) [54], epidermal growth factor (EGF) [83, 84], hepatoma-derived growth factor (HDGF) [85], IL-8 [54], platelet-derived growth factor (PDGF) [84], stromal cell-derived factor-1 (SDF1, a.k.a. CXCL12) [86, 87], TGFβ [88], and VEGF [84].”

    From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [54]

    Citation [54] is attached to CXCL1 and IL-8, not to the other listed factors. In Results, the paper reports that both are secreted by Hec1a tumor cells and that bone marrow-derived MSC and omental adipose stromal cells migrate in response to tumor-conditioned medium. It says CXCL1 and IL-8 may trigger chemotaxis, rather than establishing that either factor drives tumor tropism. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • All MSC populations share basic immunophenotypic and functional similarities, but high-resolution techniques reveal differences that are also reflected in variability of their secretome.

    “Although all MSC populations share basic similarities immunophenotypically and functionally, differences can be demonstrated using high resolution techniques [52, 53] and are reflected in variability within their secretome [7, 54].”
  • Subcutaneous adipose-derived MSC populations appear to secrete lower levels of VEGF than bone marrow-derived MSC or visceral adipose-derived stem/stromal cells.

    “Subcutaneous adipose-derived MSC populations seem to secrete lower level of VEGF than BM-MSC [7, 54] or visceral ASC [54].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Klopp, A. H., Zhang, Y., Solley, T., Amaya-Manzanares, F., Marini, F., Andreeff, M., Debeb, B., Woodward, W., Schmandt, R., Broaddus, R., Lu, K., & Kolonin, M. G.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Authors' Affiliations: Departments of 1Radiation Oncology, 2Leukemia, 3Gynecologic Oncology, and 4Pathology, The University of Texas MD Anderson Cancer Center; and 5The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas
Corresponding author
Kolonin, Mikhail G.
Venue
Clinical Cancer Research
Published
2012-01-31
Volume
18
Issue
3
Pages
771-782
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2126961122
Cited by
178
References
49
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 19 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 11 · 2018: 13 · 2017: 17 · 2016: 12 · 2015: 21 · 2014: 16 · 2013: 22 · 2012: 8
FWCI
7.47
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (KG080782)
  • National Cancer Institute (P50CA098258, P50CA140388, R01CA109451, RC1CA146381, P50CA083639, P30CA016672)
  • National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
omental adipose tissue, adipose-derived stromal cells, endometrial cancer, tumor vascularization, tumor stroma, visceral adipose tissue, mesenchymal stem cells, tumor cell proliferation, tumor necrosis, cell motility, tumor microenvironment
MeSH terms
Adipose Tissue, Animals, Cell Differentiation, Female, Flow Cytometry, Humans, Neovascularization, Pathologic, Omentum, Transplantation, Heterologous, Endometrial Neoplasms, Stromal Cells, Subcutaneous Fat, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review